Evaluation of the comprehensive score for financial toxicity measure in a multicenter cohort of adults with advanced liver disease

By afschroeder • June 16, 2026

Zeng C, Aby ES, Bizup G, Zhu E, Hays RD, Edelen MO, Ufere NN; on the behalf of the PACE-LT Consortium. Evaluation of the comprehensive score for financial toxicity measure in a multicenter cohort of adults with advanced liver disease. J Patient Rep Outcomes. 2026 Jun 15. doi: 10.1186/s41687-026-01104-2. Epub ahead of print. PMID: 42295511.

Tags: Cost, Financial burden, Financial toxicity, General Internal Medicine, Liver disease, patient-reported outcome (PRO), Publications

Eosinophilic cholangitis as an indeterminate biliary mimic: A systematic review of outcomes

Stirrat T, Wilkey M, Ransibrahmanakul V, Singh L, Allen O, Kanth P, Rangnekar A, Redfield R. Eosinophilic cholangitis as an indeterminate biliary mimic: A systematic[...]

Real-world clinical outcomes of Trastuzumab Deruxtecan in HER2-expressing ovarian and endometrial Cancer

Silverstein J, Alomaja O, Chatram D, Hajiabbasi M, Shachar E, Tseng CH, Thaker S, Bardia A, Karlan B, Hendrickson AW, Konecny GE. Real-world clinical outcomes[...]

Beyond Glycemia: Entering the Era of Hard Outcomes for Continuous Glucose Monitoring

Alkabbani W, Cromer SJ, Patorno E. Beyond Glycemia: Entering the Era of Hard Outcomes for Continuous Glucose Monitoring. Diabetes Care. 2026 Sep 1;49(9):1554-1556. doi: 10.2337/dci26-0084.[...]